MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS

间日疟原虫表面抗原的分子分析

基本信息

  • 批准号:
    8172324
  • 负责人:
  • 金额:
    $ 5.48万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-05-01 至 2011-04-30
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term objective of this research is to provide fundamental molecular biological and immunobiological information tosupport the development of a blood-stage vaccine against Plasmodium vivax, one of the two most prevalent species of human malaria. This research is also relevant for increasing the understanding of the biology of P. falciparum, the other major species of human malaria. The related non-human primate malarias P. cynomolgi, P. coatneyi and P. knowlesi, which infected rhesus monkeys, are excellent models for these investigations. This project entails the characterization of several Plasmodium merozoite proteins and the genes encoding them, with emphasis on molecules that 1) have an apparent direct or indirect function in the receptor mediated processes of merozoite invasion of erythrocytes, and 2) are likely to have a role in affecting the immunobiological relationship between P. vivax and humans by stimulating anti-P. vivax immune responses. The coordinated use of in-vitro merozoite invasion and attachment assays, immunoelectron microscopy, gene knockout technologies, defined antibody and recombinant DNA reagents, and the use of the simian malaria models, aid in the precise determination and clarification of the location(s), function, structure and possible interactive relationships of the merozoite proteins under investigation. This year, our report on the identification of the normocyte binding protein family in P. knowlesi was published, and manuscripts on the discovery of a PkNBP erythrocyte binding domain, the Pv and Pk RhopH complex, the 11 member Pv MSP3 family, and P. cynomolgi PHIST protein and family are under review for submission. A manuscript defining a novel merozoite apical protein (MAP) is being prepared. This year, extensive transcriptome and proteome data have also been generated and analyzes are underway in preparation for manuscripts and the design of new directions. Further, three reviews have been published and support provided for a study on chimeric vaccine development and testing.
这个子项目是众多研究子项目之一

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MARY R GALINSKI其他文献

MARY R GALINSKI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MARY R GALINSKI', 18)}}的其他基金

Integrated Approach to Host-Pathogen Interactions
宿主-病原体相互作用的综合方法
  • 批准号:
    8564414
  • 财政年份:
    2012
  • 资助金额:
    $ 5.48万
  • 项目类别:
Plasmodium cynomolgi as a model for P. vivax.
食蟹猴疟原虫作为间日疟原虫的模型。
  • 批准号:
    8290557
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RBL Binding Domain Malaria Candidate Vaccines
RBL 结合域疟疾候选疫苗
  • 批准号:
    8104854
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
网状细胞结合样 (RBL) 蛋白作为新一代疟疾疫苗
  • 批准号:
    8357495
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
MOLECULAR ANALYSIS OF PLASMODIUM VIVAX SURFACE ANTIGENS
间日疟原虫表面抗原的分子分析
  • 批准号:
    8357395
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
RBL Binding Domain Malaria Candidate Vaccines
RBL 结合域疟疾候选疫苗
  • 批准号:
    8231986
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
MOLECULAR BASIS OF ANTIGENIC VARIATION ON MALARIA
疟疾抗原变异的分子基础
  • 批准号:
    8357390
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
Plasmodium cynomolgi as a model for P. vivax.
食蟹猴疟原虫作为间日疟原虫的模型。
  • 批准号:
    8177389
  • 财政年份:
    2011
  • 资助金额:
    $ 5.48万
  • 项目类别:
PLASMODIUM VIVAX MSP-3 AND MSP-9 AS VACCINE IMMUNOGENS
间日疟原虫 MSP-3 和 MSP-9 作为疫苗免疫原
  • 批准号:
    8172356
  • 财政年份:
    2010
  • 资助金额:
    $ 5.48万
  • 项目类别:
RETICULOCYTE BINDING-LIKE (RBL) PROTEINS AS NEW GENERATION MALARIA VACCINES
网状细胞结合样 (RBL) 蛋白作为新一代疟疾疫苗
  • 批准号:
    8172457
  • 财政年份:
    2010
  • 资助金额:
    $ 5.48万
  • 项目类别:

相似海外基金

University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
  • 批准号:
    10073243
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
  • 批准号:
    10752129
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
  • 批准号:
    2339201
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Research Grant
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
  • 批准号:
    23K14783
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
  • 批准号:
    23KJ0394
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
  • 批准号:
    10076445
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
    Grant for R&D
PLA2G2D Antibodies for Cancer Immunotherapy
用于癌症免疫治疗的 PLA2G2D 抗体
  • 批准号:
    10699504
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Genetic adjuvants to elicit neutralizing antibodies against HIV
基因佐剂可引发抗艾滋病毒中和抗体
  • 批准号:
    10491642
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
Novel Immunogens to Elicit Broadly Cross-reactive Antibodies That Target the Hemagglutinin Head Trimer Interface
新型免疫原可引发针对血凝素头三聚体界面的广泛交叉反应抗体
  • 批准号:
    10782567
  • 财政年份:
    2023
  • 资助金额:
    $ 5.48万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了